Spark Therapeutics’ promising gene therapy for vision loss could cost $1 million
October 13, 2017 at 15:44 PM EDT
The development could be a major, if costly, milestone for both the disease and the field of gene therapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|